Twitter is trying to stifle Elon Musk.
On Friday, the social media company unrolled a defense against Musk’s unwelcome takeover bid, introducing what is known as a poison pill to fend off Musk’s $43 billion acquisition attempt.
The maneuver, formally called a shareholder rights plan, essentially allows current shareholders to acquire more stock in the company at a discount, presenting Musk with a unwelcome “pill,” meaning his shares would become diluted and his purchase would become more expensive. It would require that Musk negotiate directly with Twitter’s board on any purchase attempt.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
